0001140361-21-009200.txt : 20210318 0001140361-21-009200.hdr.sgml : 20210318 20210318211408 ACCESSION NUMBER: 0001140361-21-009200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210315 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldman Neil A CENTRAL INDEX KEY: 0001726644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35569 FILM NUMBER: 21756258 MAIL ADDRESS: STREET 1: 3661 HORSEBLOCK RD CITY: MEDFORD STATE: NY ZIP: 11763 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC. CENTRAL INDEX KEY: 0001092662 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880425691 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 BUSINESS PHONE: (631) 924-1135 MAIL ADDRESS: STREET 1: 555 WIRELESS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 FORMER COMPANY: FORMER CONFORMED NAME: Chembio Diagnostics Inc. DATE OF NAME CHANGE: 20040607 FORMER COMPANY: FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC DATE OF NAME CHANGE: 19990805 4 1 form4.xml FORM 4 X0306 4 2021-03-15 0001092662 CHEMBIO DIAGNOSTICS, INC. CEMI 0001726644 Goldman Neil A C/O CHEMBIO DIAGNOSTICS, INC. 555 WIRELESS BOULEVARD HAUPPAUGE NY 11788 true See Remarks Restricted Stock Units 2021-03-15 4 A 0 38710 0 A Common Stock 38710 38710 D Incentive Stock Options 4.65 2021-03-15 4 A 0 107143 0 A 2028-03-14 Common Stock 107143 107143 D Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units are scheduled to vest over three years, with one-third vesting on March 15, 2022, one-third vesting on March 15, 2023, and the remaining one-third vesting on March 15, 2024, subject to continued service through each vesting date. The incentive stock options are scheduled to vest and become exercisable over four years, with one-fourth vesting on March 15, 2022, one-fourth vesting on March 15, 2023, one-fourth vesting on March 15, 2024 and the remaining one-fourth vesting on March 15, 2025, subject to continued service through each vesting date. Executive Vice President, Chief Financial Officer /s/ Mark L. Johnson, Attorney-in-Fact for Neil A. Goldman 2021-03-18